Enhanced induction of Bax gene expression in H460 and H1299 cells with the combined treatment of cisplatin and adenovirus mediated wt-p53 gene transfer

Experimental and Molecular Medicine

Volumn 32, Issue 1, 2000, Pages 23-28

  Choi, Ji Hyung ^a   Ahn, Kwang Sung ^b   Kim, Jhingook ^c   Hong, Young Sook ^a  

^a Ewha Womans University School of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Apoptosis; Avp53; Bax; Cisplatin; Combined treatment

Indexed keywords

CISPLATIN; INTERLEUKIN 1BETA CONVERTING ENZYME; PHOSPHOPROTEIN; PROTEIN BAX; PROTEIN P21; PROTEIN P53;

ADENOVIRUS; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG CYTOTOXICITY; GENE INDUCTION; GENE TRANSFER; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LUNG CANCER; PROTEIN PHOSPHORYLATION; TUMOR SUPPRESSOR GENE;

ADENOVIRIDAE;

EID: 0034737753     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2000.5     Document Type: Article

References (23)

1. Anne, F., Jacqueline, D. S., Jean, C. A., Jean, G. R. Jean, F. B., Guy, R. and Jean, B. (1996) Cisplatin-induced apoptosis and p53 gene status in a cisplatin-resistant human ovarian carcinoma cell line. Int. J. Caner. 68: 67-74
2. Annette, J. H., Christopher, A. S., Leslie, C. S., Victoria, E. A. S., Vanessa, L. L., Aedin, C. C. and Gwyn, T. W. (1996) Apoptosis: molecular regulation of cell death. Eur. J. Biochem. 236: 1-26
3. Araki, R., Fukumura, R., Fujimori, A., Taya, Y., Shiloh, Y., Kurimasa, A., Burma, S., Li, G. C., Chen, D. J., Sato, K., Hoki, Y., Tatsumi, K. and Abe, M. (1999) Enhanced phosphorylation of p53 serine 18 following DNA damage in DNA-dependent protein kinase catalytic subunit-deficinet cells. Cancer Res. 59: 3543-3546
4. Aristides, G. E., David, J. K., Jonathan, H., Liz, H., Stanislaw, K., John, C. R. and Lawrence, S. Y. (1995) The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2. Oncogene. 11: 1217-1228
5. Badie, B., Goh, C. S., Klaver, J., Herweijer, H. and Boothman, D. A. (1999) Combined radiation and p53 gene therapy of malignant glioma cells. Cancer Gene Therapy. 6: 155-162
6. Chen, Z., Naito, M., Mashima, T. and Tsuruo, T. (1996) Activation of actin-cleavable interieukin 1 beta-converting enzyme (ICE) family protease CPP-32 during chemotherapeutic agent-induced apoptosis in ovarian carcinoma cells. Cancer Res. 56: 5224-9
7. Eichholtz, W. H., Stoetzer, O. and Marx, K. (1997) Reduced expression of the ICE-related protease CPP32 is associated with radiation-induced cisplatin resistance in HeLa cells. Br. J. Cancer. 76: 1322-7
8. Fujiwara, T., Grimm, E. A., Mukhopadhyay, T., Zhang, W. W., Owen-Schaub, L. B. and Roth, J. A. (1994) Induction of chemotherapy in human lung cancer cells in vivo by adenovirus-mediate transfer of wild-type p53 gene. Cancer. Res. 54: 2287-91
9. Haapajarvi, T., Kivinen, L., Heiskanen, A., des Bordes, C., Datto, M. B., Wang, X. F. and Laiho, M. (1999) UV radiation is a transcriptional inducer of p21(Cip1/Waf1) cyclin-kinase inhibitor in a p53-independent manner. Exp. Cell. Res 248: 272-9
10. Hale, A. J., Smith, C. A., Sutherland, L. C., Stoneamn, V. E., Longthorne, V. L., Culhane, A. C. and Williams, G. T. (1991) Apoptosis: molecule regulation of cell death. Eur. J. Biochem. 236: 49
11. Kim, J., Lee, S. K., Hwang E. S., Kim, J. S., Kim K. and Lee, J. H. (1997) Limited cytotoxic effect of adenoviral-mediated p53 gene transfer in variable non-small cell lung cancer (NSCLC) cell lines. J. Korean. Cancer. 29: 565-575
12. Lowe, S. W., Ruley, H. E., Jacks, T. and Housman, D. E. (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 74: 957-967
13. Levine, A. J. (1997) p53, the cellular gatekeeper for growth and division. Cell. 88: 323-331
14. Michael, W. (1998) Predicting reponse to cancer chemotherapy: the role of p53. Cell. Tissue. 292: 435-445
15. Mikhail, V. B., Paraskevi, G. and Malgorzata, W. (1998) Effects of p53-expressing adenovirus on the chemosensitivity and differentiation of anaplastic thyroid cancer cells. J. Clinical. Endocrinol & Metabolism. 83: 2516-2522.
16. Miyashita, T., Krajewski. S., Krajewska, M., et al. (1994) Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 9: 1799-1809
17. Müller, H and Eppenberger, U. (1996) The dual role of mutant p53 protein in chemosensitivity of human cancer. Anticancer. Res. 16: 3845-3848
18. Nguyen, D. M., Spitz, F. R., Yen, N., Cristiano, R. J. and Roth, J. A. (1996) Gene therapy for lung cancer: enhancement of tumor suppression by a combination of sequential systemic cisplatin and adenovirus-mediated p53 gene transfer. J. Thorac. Cardiovasc. Surg. 112: 1372-1377
19. Ogawa, N., Fujiwara, T., Kagawa, S., Nishizaki, M., Morimoto, Y., Tanida, T., Hizuta, A., Yasuda, T., Roth, J. A. and Tanaka, N. (1997) Novel combination therapy for human colon cancer with adenovirus-mediated wild-type p53 gene transfer and DNA-damaging chemotherapeutic agent. Int. J. Cancer. 73: 367-370
20. Perego, P., Giarola, M., Righetti, S. C., Supino, R., Caserini, C., Delia, D., Pierotti, M. A., Miyashita, T., Reed, J. C. and Zunino, F. (1996) Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems. Cancer Res 156: 556-62
21. Rusch, V., Klimstra, D. and Venkatraman, E. (1995) Aberrant p53 expression predicts clinical resistance to cisplatin-based chemotherapy in locally advanced non-small-cell lung cancer. Cancer Res. 55: 5038-5042
22. Ulisses, G. L., Peter, E., Ryoji, Y. and Geoffrey, M. C. (1997) p53-dependent induction of apoptosis by proteasome inhibitors. J. Biol. Chem. 272: 12893-12896
23. Wang, X., Liu, Y., Chow, L. S., Wong, S. C., Tsao, S. W., Kwong, D. L., Wang, J., Sham, J. S., Nicholls, J. M. (1999) Cisplatin-induced p53-independent growth arrest and cell death in cancer cells. Int. J. Oncol. 15: 1097-1102